S&P 500 7,584.31 ▲ 30.63 (+0.41%) DOW 51,561.93 ▲ 874.86 (+1.73%) NASDAQ 26,830.96 â–ŧ 23.02 (-0.09%) US Markets Closed â€ĸ 06:46 AM ET

BLGO

BioLargo, Inc.

Price Chart
Latest Quote

$0.11

+0.00 (+0.18%)
Current Price
Previous Close $0.11
Open $0.12
Day High $0.12
Day Low $0.11
Volume 132,666
Fetched: 2026-06-05T10:46:15
Stock Information
Shares Outstanding 320.88M
Total Debt $5.66M
Cash Equivalents $4.12M
Revenue $5.61M
Net Income $-12.91M
Sector Basic Materials
Industry Chemicals
Market Cap $35.46M
EPS (TTM) $-0.05
Exchange OQX
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$36.23M
Sales$5.61M
Income$-12.91M
Book/sh$0.01
Cash/sh$0.01
Employees44
Financial Ratios
Quick Ratio0.98
Current Ratio1.10
Returns & Margins
ROA-106.04%
ROE-680.11%
Gross Margin42.35%
Operating Margin-287.35%
Profit Margin-230.10%
Ownership
Insider Ownership13.61%
Institutional Ownership0.04%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-2.76
PEG2.71
P/S6.32
P/B8.50
Analyst Data
Recommendationnone
Target Price$0.32
Technical Indicators
SMA20$0.13
SMA50$0.14
SMA200$0.17
RSI43.75
ATR0.0179
Shares Float253.27M
Rel Volume0.30
Performance History
Week-21.43%
Month-31.25%
Quarter-35.29%
6 Months-42.11%
YTD-42.11%
Year-47.62%
3 Years-42.11%
5 Years-35.29%
10 Years-73.81%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-04 $0.11 219,000
2026-06-03 $0.12 1,095,400
2026-06-02 $0.10 3,910,500
2026-06-01 $0.12 336,800
2026-05-29 $0.13 517,100
2026-05-28 $0.14 268,100
2026-05-27 $0.13 200,000
2026-05-26 $0.14 509,500
2026-05-22 $0.15 345,400
2026-05-21 $0.14 1,278,000
2026-05-20 $0.11 490,700
2026-05-19 $0.11 1,324,800
2026-05-18 $0.12 675,100
2026-05-15 $0.13 147,300
2026-05-14 $0.13 239,400
2026-05-13 $0.13 680,700
2026-05-12 $0.14 254,400
2026-05-11 $0.14 1,715,000
2026-05-08 $0.15 199,100
2026-05-07 $0.16 182,500
2026-05-06 $0.15 420,900
2026-05-05 $0.16 151,700
About BioLargo, Inc.

BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.

Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $9,926,000 $6,076,000 $3,027,000 $1,428,000
Cost Of Revenue $9,926,000 $6,076,000 $3,027,000 $1,428,000
Total Revenue $17,779,000 $12,230,000 $5,884,000 $2,531,000
Operating Revenue $17,779,000 $12,230,000 $5,884,000 $2,531,000
Expenses
Interest Expense $33,000 $91,000 $53,000 $234,000
Total Expenses $22,084,000 $16,393,000 $10,940,000 $8,892,000
Other Income Expense $97,000 $-394,000 $-23,000 $-299,000
Net Non Operating Interest Income Expense $-139,000 $-91,000 $-53,000 $-234,000
Total Other Finance Cost $106,000 - - -
Interest Expense Non Operating $33,000 $91,000 $53,000 $234,000
Operating Expense $12,158,000 $10,317,000 $7,913,000 $7,464,000
Other Operating Expenses $-26,000 $-36,000 $-74,000 $-55,000
Selling And Marketing Expense $494,000 $481,000 $287,000 -
General And Administrative Expense $8,808,000 $7,577,000 $6,444,000 -
Other Non Operating Income Expenses - - $63,000 $20,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-2,402,000 $-3,504,000 $-4,473,000 $-7,080,000
Net Interest Income $-139,000 $-91,000 $-53,000 $-234,000
Normalized Income $-2,499,000 $-3,110,000 $-4,450,000 $-6,781,000
Net Income From Continuing And Discontinued Operation $-2,402,000 $-3,504,000 $-4,473,000 $-7,080,000
Total Operating Income As Reported $-4,331,000 $-4,580,000 $-5,390,000 $-6,778,000
Net Income Common Stockholders $-2,402,000 $-3,504,000 $-4,473,000 $-7,080,000
Net Income $-2,402,000 $-3,504,000 $-4,473,000 $-7,080,000
Net Income Including Noncontrolling Interests $-4,347,000 $-4,648,000 $-5,132,000 $-6,894,000
Net Income Continuous Operations $-4,347,000 $-4,648,000 $-5,132,000 $-6,894,000
Pretax Income $-4,347,000 $-4,648,000 $-5,132,000 $-6,894,000
Special Income Charges $97,000 $-394,000 $-23,000 $-299,000
Operating Income $-4,305,000 $-4,163,000 $-5,056,000 $-6,361,000
Gross Profit $7,853,000 $6,154,000 $2,857,000 $1,103,000
Per Share
Diluted EPS $-0.01 $-0.01 $-0.02 $-0.03
Basic EPS $-0.01 $-0.01 $-0.02 $-0.03
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-4,156,000 $-3,891,000 $-5,011,000 $-6,341,000
Total Unusual Items $97,000 $-394,000 $-23,000 $-299,000
Total Unusual Items Excluding Goodwill $97,000 $-394,000 $-23,000 $-299,000
Reconciled Depreciation $255,000 $272,000 $45,000 $20,000
EBITDA (Bullshit earnings) $-4,059,000 $-4,285,000 $-5,034,000 $-6,640,000
EBIT $-4,314,000 $-4,557,000 $-5,079,000 $-6,660,000
Diluted Average Shares $298,122,239 $285,956,852 $268,302,234 $247,203,625
Basic Average Shares $298,122,239 $285,956,852 $268,302,234 $247,203,625
Diluted NI Availto Com Stockholders $-2,402,000 $-3,504,000 $-4,473,000 $-7,080,000
Minority Interests $1,945,000 $1,144,000 $659,000 $-186,000
Other Special Charges $-97,000 - $-174,000 $-43,000
Write Off $0 $394,000 $197,000 $342,000
Other Taxes $0 $13,000 $-63,000 $-20,000
Research And Development $2,882,000 $2,282,000 $1,319,000 $1,367,000
Selling General And Administration $9,302,000 $8,058,000 $6,731,000 $6,172,000
Other Gand A $5,110,000 $4,397,000 $3,289,000 -
Salaries And Wages $3,698,000 $3,180,000 $3,155,000 -
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $8,817,000 $6,810,000 $4,844,000 $4,619,000
Total Assets $10,513,000 $8,205,000 $4,858,000 $3,023,000
Total Non Current Assets $3,376,000 $1,843,000 $1,705,000 $1,222,000
Non Current Prepaid Assets $61,000 $36,000 $430,000 $626,000
Non Current Note Receivables $82,000 $0 - -
Goodwill And Other Intangible Assets $34,000 $34,000 $34,000 $34,000
Other Intangible Assets $34,000 $34,000 $34,000 $34,000
Current Assets $7,137,000 $6,362,000 $3,153,000 $1,801,000
Other Current Assets $91,000 $58,000 $118,000 $85,000
Inventory $330,000 $153,000 $120,000 $241,000
Receivables $3,168,000 $2,612,000 $1,064,000 $513,000
Accounts Receivable $3,168,000 $2,612,000 $1,064,000 $513,000
Allowance For Doubtful Accounts Receivable $-97,000 $-84,000 $-12,000 $-12,000
Gross Accounts Receivable $3,265,000 $2,696,000 $1,076,000 $525,000
Cash Cash Equivalents And Short Term Investments $3,548,000 $3,539,000 $1,851,000 $962,000
Cash And Cash Equivalents $3,548,000 $3,539,000 $1,851,000 $962,000
Cash Financial $3,548,000 $3,539,000 $1,851,000 -
Non Current Accounts Receivable - - $54,000 -
Other Non Current Assets - - - $69,000
Prepaid Assets - - - $85,000
Debt
Total Debt $2,554,000 $1,698,000 $1,468,000 $1,133,000
Long Term Debt And Capital Lease Obligation $1,809,000 $1,293,000 $1,271,000 $716,000
Long Term Debt $527,000 $289,000 $498,000 $367,000
Current Debt And Capital Lease Obligation $745,000 $405,000 $197,000 $417,000
Current Debt $552,000 $300,000 $100,000 $314,000
Other Current Borrowings $552,000 $300,000 $100,000 $314,000
Liabilities
Total Liabilities Net Minority Interest $4,457,000 $4,003,000 $2,847,000 $2,090,000
Total Non Current Liabilities Net Minority Interest $1,809,000 $1,293,000 $1,271,000 $716,000
Current Liabilities $2,648,000 $2,710,000 $1,576,000 $1,374,000
Other Current Liabilities $90,000 $117,000 $184,000 $79,000
Current Deferred Liabilities $0 $303,000 $17,000 $89,000
Payables And Accrued Expenses $1,813,000 $1,885,000 $1,178,000 $789,000
Interest Payable $0 $38,000 $32,000 $76,000
Payables $1,663,000 $1,589,000 $903,000 $499,000
Dividends Payable $590,000 $242,000 $0 -
Accounts Payable $1,073,000 $1,347,000 $903,000 $499,000
Equity
Common Stock Equity $8,851,000 $6,844,000 $4,878,000 $4,653,000
Total Equity Gross Minority Interest $6,056,000 $4,202,000 $2,011,000 $933,000
Stockholders Equity $8,851,000 $6,844,000 $4,878,000 $4,653,000
Gains Losses Not Affecting Retained Earnings $-183,000 $-277,000 $-149,000 $-115,000
Other Equity Adjustments $-183,000 $-277,000 $-149,000 $-115,000
Retained Earnings $-149,500,000 $-147,098,000 $-143,594,000 $-139,121,000
Long Term Equity Investment $14,000 $19,000 $33,000 $48,000
Other
Ordinary Shares Number $301,274,243 $292,945,747 $278,462,706 $255,893,726
Share Issued $301,274,243 $292,945,747 $278,462,706 $255,893,726
Tangible Book Value $8,817,000 $6,810,000 $4,844,000 $4,619,000
Invested Capital $9,930,000 $7,433,000 $5,476,000 $5,334,000
Working Capital $4,489,000 $3,652,000 $1,577,000 $427,000
Capital Lease Obligations $1,475,000 $1,109,000 $870,000 $452,000
Total Capitalization $9,378,000 $7,133,000 $5,376,000 $5,020,000
Minority Interest $-2,795,000 $-2,642,000 $-2,867,000 $-3,720,000
Additional Paid In Capital $158,332,000 $154,023,000 $148,435,000 $143,718,000
Capital Stock $202,000 $196,000 $186,000 $171,000
Common Stock $202,000 $196,000 $186,000 $171,000
Preferred Stock $0 $0 $0 $0
Long Term Capital Lease Obligation $1,282,000 $1,004,000 $773,000 $349,000
Current Deferred Revenue $0 $303,000 $17,000 $89,000
Current Capital Lease Obligation $193,000 $105,000 $97,000 $103,000
Current Accrued Expenses $150,000 $296,000 $275,000 $290,000
Investments And Advances $14,000 $19,000 $33,000 $48,000
Investmentsin Joint Venturesat Cost $14,000 $19,000 $33,000 $48,000
Net PPE $3,185,000 $1,754,000 $1,154,000 $514,000
Accumulated Depreciation $-462,000 $-363,000 - -
Gross PPE $3,647,000 $2,117,000 $1,154,000 $514,000
Leases $526,000 $572,000 - -
Other Properties $3,121,000 $1,545,000 $1,154,000 $514,000
Properties $0 $0 - -
Finished Goods $120,000 $74,000 $74,000 $133,000
Raw Materials $210,000 $79,000 $46,000 $108,000
Line Of Credit - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-4,441,000 $-2,843,000 $-3,033,000 $-3,971,000
Operating Activities
Operating Cash Flow $-3,206,000 $-2,365,000 $-2,762,000 $-3,937,000
Cash Flow From Continuing Operating Activities $-3,206,000 $-2,365,000 $-2,762,000 $-3,937,000
Operating Gains Losses $14,000 $44,000 $-159,000 $-28,000
Investing Activities
Capital Expenditure $-1,235,000 $-478,000 $-271,000 $-34,000
Investing Cash Flow $-1,317,000 $-478,000 $-271,000 $-34,000
Cash Flow From Continuing Investing Activities $-1,317,000 $-478,000 $-271,000 $-34,000
Net Other Investing Changes $-82,000 - - -
Financing Activities
Issuance Of Capital Stock $2,649,000 $4,618,000 $3,842,000 $4,932,000
Financing Cash Flow $4,438,000 $4,659,000 $3,956,000 $4,231,000
Cash Flow From Continuing Financing Activities $4,438,000 $4,659,000 $3,956,000 $4,231,000
Net Preferred Stock Issuance $0 $1,575,000 $225,000 $0
Preferred Stock Issuance $0 $1,575,000 $225,000 $0
Net Common Stock Issuance $2,649,000 $3,043,000 $3,617,000 $4,932,000
Common Stock Issuance $2,649,000 $3,043,000 $3,617,000 $4,932,000
Other
Repayment Of Debt $-14,000 $-27,000 $-26,000 $-865,000
Issuance Of Debt $864,000 $65,000 $100,000 $0
Interest Paid Supplemental Data $33,000 $58,000 $36,000 $99,000
Income Tax Paid Supplemental Data $0 $0 $3,000 $2,000
End Cash Position $3,548,000 $3,539,000 $1,851,000 $962,000
Beginning Cash Position $3,539,000 $1,851,000 $962,000 $716,000
Effect Of Exchange Rate Changes $94,000 $-128,000 $-34,000 $-14,000
Changes In Cash $-85,000 $1,816,000 $923,000 $260,000
Proceeds From Stock Option Exercised $939,000 $3,000 $40,000 $164,000
Net Issuance Payments Of Debt $850,000 $38,000 $74,000 $-865,000
Net Long Term Debt Issuance $850,000 $38,000 $74,000 $-865,000
Long Term Debt Payments $-14,000 $-27,000 $-26,000 $-865,000
Long Term Debt Issuance $864,000 $65,000 $100,000 $0
Net PPE Purchase And Sale $-1,235,000 $-478,000 $-271,000 $-21,000
Purchase Of PPE $-1,235,000 $-478,000 $-271,000 $-21,000
Change In Working Capital $-1,620,000 $-1,077,000 $-250,000 $249,000
Change In Other Working Capital $-303,000 $286,000 $-72,000 $120,000
Change In Other Current Liabilities $-82,000 $-155,000 $3,000 -
Change In Payables And Accrued Expense $-404,000 $465,000 $390,000 $179,000
Change In Prepaid Assets $-85,000 $49,000 $15,000 $-57,000
Change In Inventory $-177,000 $-89,000 $-35,000 $36,000
Change In Receivables $-569,000 $-1,633,000 $-551,000 $-29,000
Changes In Account Receivables $-569,000 $-1,633,000 $-551,000 $-29,000
Other Non Cash Items $416,000 $387,000 $308,000 $502,000
Stock Based Compensation $2,063,000 $2,124,000 $2,071,000 $1,872,000
Provisionand Write Offof Assets $0 $54,000 $158,000 $0
Asset Impairment Charge $13,000 $479,000 $197,000 $342,000
Depreciation Amortization Depletion $255,000 $272,000 $45,000 $20,000
Depreciation And Amortization $255,000 $272,000 $45,000 $20,000
Depreciation $255,000 $272,000 $0 -
Earnings Losses From Equity Investments $5,000 $14,000 $15,000 $15,000
Gain Loss On Investment Securities $106,000 $30,000 - -
Net Income From Continuing Operations $-4,347,000 $-4,648,000 $-5,132,000 $-6,894,000
Amortization Cash Flow - $103,000 $45,000 -
Amortization Of Intangibles - $103,000 $45,000 -
Net Intangibles Purchase And Sale - - $0 $-13,000
Purchase Of Intangibles - - $0 $-13,000
Net Short Term Debt Issuance - - - $0
Short Term Debt Issuance - - - $0
Net Business Purchase And Sale - - - $0
Purchase Of Business - - - $0
Fetched: 2026-02-02